Sera Prognostics SERA
NASDAQ SERA
$2.07 +0.08 (+4.02%)
As of: Aug 20, 2026 · 3:59 PM EDT

Sera Prognostics (SERA) Debt Ratio (2020)

Sera Prognostics' (SERA) quarterly Debt Ratio came in at 0.32 in Q4 2020.

Sera Prognostics (SERA) Debt Ratio (2020) Analysis & Trends

Sera Prognostics (SERA) has 1 years of Debt Ratio data on file, last reported at 0.32 in Q4 2020.

  • Quarterly Debt Ratio changed N/A year-over-year to 0.32 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 0.32 (changed N/A YoY) and the FY2020 annual result came in at 0.32, changed N/A from the prior year.
  • Debt Ratio held at 0.32 in Q4 2020.
  • In the past five years, Debt Ratio ranged from a high of 0.32 in Q4 2020 to a low of 0.32 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 0.30
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 0.31
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 0.30
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 0.28
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 0.04
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 0.27
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 0.28
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 0.18
10 Sera Prognostics 103.48 Mn 103.48 Mn -20,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2020 0.32